Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group (Q33372613)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group
scientific article

    Statements

    Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group (English)
    Agop Y Bedikian
    Michael Millward
    Hubert Pehamberger
    Robert Conry
    Anna C Pavlick
    Ronald DeConti
    Evan M Hersh
    Peter Hersey
    John M Kirkwood
    Frank G Haluska
    Oblimersen Melanoma Study Group
    11 September 2006
    4738-4745

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit